Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Danube Pharmaceuticals, which is engaged in the commercial R&D of drugs for ophthalmology, has appointed Brian Levy as its new COO.
Subscribe to our email newsletter
Prior to joining Danube, since 2004, Dr Levy served as corporate vice president and chief medical officer of Bausch & Lomb worldwide. Dr Levy joined Bausch & Lomb in 1994 as director of medical clinical affairs. Prior to joining Bausch & Lomb, from 1989 to 1994, Dr Levy served as associate professor in the department of ophthalmology at California Pacific Medical Center in San Francisco.
Barrett Katz, CEO of Danube, said: “Dr Levy’s depth and breadth of experience in clinical operations, drug and device development and medical affairs make him an excellent addition to Danube’s senior management team. I look forward to his working with us in successfully developing our drug candidates and expanding our pipeline.”